Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

9 Results
Document type : Journal articles
Document type : Conference papers
Document type : Conference poster
Document type : Books
Document type : Book sections
Document type : Directions of work or proceedings
Document type : Patents
Document type : Other publications
hal_authIdPerson_i : 749083
Image document

Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial

Nicolas Boissel , Aline Renneville , Thibaut Leguay , Pascale Cornillet Lefebvre , Christian Recher , et al.
Haematologica, 2015, 100 (6), pp.780 - 785. ⟨10.3324/haematol.2014.114884⟩
Journal articles inserm-01820455v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas , et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation

Anne Bouvier , Jeremie Riou , Sylvain Thépot , Aurélien Sutra del Galy , Sylvie Francois , et al.
Leukemia, 2019, 19 (1), ⟨10.1038/s41375-019-0624-4⟩
Journal articles hal-02416159v1

Study of mitochondrial function in placental insufficiency

Tiphaine Lefebvre , Ombeline Roche , Valerie Seegers , Majida Cherif , Salim Khiati , et al.
Placenta, 2018, 67, pp.1-7. ⟨10.1016/j.placenta.2018.05.007⟩
Journal articles hal-02388228v1

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.

Sarah Bertoli , Pierre Bories , Marie C Béné , Sylvie Daliphard , Bruno Lioure , et al.
Haematologica, 2013, epub ahead of print. ⟨10.3324/haematol.2013.091819⟩
Journal articles hal-00854975v1

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.

Bruno Lioure , Marie C Béné , Arnaud Pigneux , Anne Huynh , Patrice Chevallier , et al.
Blood, 2012, 119 (12), pp.2943-8. ⟨10.1182/blood-2011-05-352989⟩
Journal articles hal-00849702v1

Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

C. Willekens , O. Blanchet , A. Renneville , P. Cornillet-Lefebvre , C. Pautas , et al.
Haematologica, 2016, 101 (3), pp.328 - 335. ⟨10.3324/haematol.2015.131946⟩
Journal articles inserm-01817446v1

Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression

Laurane Cottin , Jeremie Riou , Corentin Orvain , Jean Christophe Ianotto , Françoise Boyer , et al.
British Journal of Haematology, 2019, Epub ahead of print. ⟨10.1111/bjh.16276⟩
Journal articles inserm-02467617v1

Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH

J. Boursier , R. Anty , L. Vonghia , V. Moal , T. Vanwolleghem , et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2018, 47 (10), pp.1387-1396. ⟨10.1111/apt.14621⟩
Journal articles hal-02448804v1